Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 6 , Pages 460-465 , November 2009

Therapeutic Interventions and Success in Risk Factor Control for Secondary Prevention of Stroke

  • Jose Alvarez-Sabin, MD, PhD

      Affiliations

    • Unitat Neurovascular vall d' Hebron, Neurology Service Hospital vall d' Hebron, Barcelona, Spain
    • ,
  • Manuel Quintana

      Affiliations

    • Unitat Neurovascular vall d' Hebron, Neurology Service Hospital vall d' Hebron, Barcelona, Spain
    • ,
  • Miguel Angel Hernandez-Presa, PhD

      Affiliations

    • Medical Unit, Pfizer Spain
    • ,
  • Carlos Alvarez, MD

      Affiliations

    • Medical Unit, Pfizer Spain
    • ,
  • Jose Chaves, PhD

      Affiliations

    • Medical Unit, Pfizer Spain
    • ,
  • Marc Ribo, MD, PhD

      Affiliations

    • Unitat Neurovascular vall d' Hebron, Neurology Service Hospital vall d' Hebron, Barcelona, Spain
    • Corresponding Author InformationAddress correspondence: Marc Ribo Unitat d'lctus, Area 24 Hores Neurologia. Hospital vall d'Hebron Passeig vall d'Hebron 119-129. Barcelona 08034, Spain.

Received 6 December 2008 ,Revised 24 January 2009 ,Accepted 30 January 2009.

References 

  1. Hardie K, Jamrozik K, Hankey GJ, et al. Trends in five-year survival and risk of recurrent stroke after first-ever stroke in the Perth community stroke study. Cerebrovasc Dis. 2005;19:179–185
  2. Hardie K, Hankey GJ, Jamrozik K, et al. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth community stroke study. Stroke. 2004;35:731–735
  3. Ingall TJ. Preventing ischemic stroke: Current approaches to primary and secondary prevention. Postgrad Med. 2000;107:34–3639-42, 47-50
  4. Holloway RG, Benesch C, Rush SR. Stroke prevention: Narrowing the evidence-practice gap. Neurology. 2000;54:1899–1906
  5. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke; co-sponsored by the Council on Cardiovascular Radiology and Intervention; the American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113:e409–e449
  6. Ovbiagele B, Saver JL, Fredieu A, et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 2004;35:2879–2883
  7. Hamann GF, Weimar C, Glahn J, et al. Adherence to secondary stroke prevention strategies–results from the German stroke data bank. Cerebrovasc Dis. 2003;15:282–288
  8. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180–189
  9. Montaner J, Vidal C, Molina C, et al. Selecting the target and the message for a stroke public education campaign: A local survey conducted by neurologists. Eur J Epidemiol. 2001;17:581–586
  10. Arif H, Aijaz B, Islam M, et al. Drug compliance after stroke and myocardial infarction: A comparative study. Neurol India. 2007;55:130–135
  11. Qizilbash N. Are risk factors for stroke and coronary disease the same?. Curr Opin Lipidol. 1998;9:325–328
  12. Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549–559
  13. Gorelick PB. Stroke prevention: An opportunity for efficient utilization of health care resources during the coming decade. Stroke. 1994;25:220–224
  14. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–2446
  15. Sud A, Kline-Rogers EM, Eagle KA, et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother. 2005;39:1792–1797
  16. Ruland S, Raman R, Chaturvedi S, et al. Awareness, treatment, and control of vascular risk factors in African Americans with stroke. Neurology. 2003;60:64–68
  17. Kernan WN, Viscoli CM, Brass LM, et al. Blood pressure exceeding national guidelines among women after stroke. Stroke. 2000;31:415–419
  18. Grumbach K, Osmond D, Vranizan K, et al. Primary care physicians' experience of financial incentives in managed-care systems. N Engl J Med. 1998;339:1516–1521
  19. Shaya FT, El Khoury AC, Mullins CD, et al. Drug therapy persistence and stroke recurrence. Am J Manag Care. 2006;12:313–319
  20. Levine DA, Kiefe CI, Howard G, et al. Reduced medication access: A marker for vulnerability in US stroke survivors. Stroke. 2007;38:1557–1564
  21. Wang Y, Wu D, Wang Y, et al. A survey on adherence to secondary ischemic stroke prevention. Neurol Res. 2006;28:16–20
  22. Grilli R, Freemantle N, Minozzi S, et al. Mass media interventions: Effects on health services utilization. Cochrane Database Syst Rev. 2000;(2):CD000389
  23. Thomson O'Brien MA, Oxman AD, Haynes RB, et al. Local opinion leaders: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2000;(2):CD000125

PII: S1052-3057(09)00033-0

doi: 10.1016/j.jstrokecerebrovasdis.2009.01.014

Journal of Stroke & Cerebrovascular Diseases
Volume 18, Issue 6 , Pages 460-465 , November 2009

Article Tools

* Image Usage & Resolution